- Home
- EBMT vs MSLE Comparison
EBMT vs MSLE Comparison
Compare EBMT & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | EBMT | MSLE |
|---|---|---|
| Founded | 1922 | N/A |
| Country | United States | Canada |
| Employees | N/A | 17 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.1M | 146.9M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBMT | MSLE |
|---|---|---|
| Price | $20.90 | $5.92 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 63.3K | ★ 112.6K |
| Earning Date | 04-28-2026 | N/A |
| Dividend Yield | ★ 2.82% | N/A |
| EPS Growth | ★ 53.23 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | $10.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.11 | $5.63 |
| 52 Week High | $23.75 | $13.39 |
Technical Indicators
Market Signals| Indicator | EBMT | MSLE |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 27.66 |
| Support Level | $15.93 | N/A |
| Resistance Level | $23.04 | $7.52 |
| Average True Range (ATR) | 0.67 | 0.72 |
| MACD | 0.05 | -0.12 |
| Stochastic Oscillator | 59.93 | 9.49 |
Price Performance
Historical ComparisonAbout EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About MSLE Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.